共 50 条
- [2] INTRINSIC SYMPATHOMIMETIC ACTIVITY OF BETA-BLOCKERS [J]. NOUVELLE PRESSE MEDICALE, 1978, 7 (31): : 2707 - 2709
- [3] BETA-BLOCKERS WITH INTRINSIC SYMPATHOMIMETIC ACTIVITY [J]. AMERICAN FAMILY PHYSICIAN, 1985, 31 (01) : 115 - 118
- [4] RELEVANCE OF INTRINSIC SYMPATHOMIMETIC ACTIVITY FOR BETA-BLOCKERS [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (09): : C21 - C23
- [5] LABETALOL HCL - ALPHA-BLOCKING AND BETA-BLOCKING PROPERTIES MAY OFFER ADVANTAGES OVER PURE BETA-BLOCKERS [J]. HOSPITAL FORMULARY, 1987, 22 (10): : 864 - 869
- [6] VASODILATING PROPERTIES OF BETA-BLOCKERS WITH INTRINSIC SYMPATHOMIMETIC ACTIVITY [J]. JOURNAL OF THE KUWAIT MEDICAL ASSOCIATION, 1982, 16 (02): : 15 - 18
- [8] DURATION OF ACTION OF BETA-BLOCKERS [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) : 593 - 601
- [9] PHARMACOLOGICAL ASPECTS OF INTRINSIC SYMPATHOMIMETIC ACTIVITY IN BETA-BLOCKING DRUGS [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (13): : F13 - F17
- [10] ANTIHYPERTENSIVE ACTION OF BETA-BLOCKERS [J]. FOLIA PHARMACOLOGICA JAPONICA, 1974, 70 (04) : P142 - P143